[1]昝双江,于智杰,李海燕.抗血小板药物在急性心肌梗死治疗中的应用[J].医学信息,2020,33(12):33-35.[doi:10.3969/j.issn.1006-1959.2020.12.011]
 ZAN Shuang-jiang,YU Zhi-jie,LI Hai-yan.Application of Antiplatelet Drugs in the Treatment of Acute Myocardial Infarction[J].Medical Information,2020,33(12):33-35.[doi:10.3969/j.issn.1006-1959.2020.12.011]
点击复制

抗血小板药物在急性心肌梗死治疗中的应用()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年12期
页码:
33-35
栏目:
综述
出版日期:
2020-06-15

文章信息/Info

Title:
Application of Antiplatelet Drugs in the Treatment of Acute Myocardial Infarction
文章编号:
1006-1959(2020)12-0033-03
作者:
昝双江于智杰李海燕
(天津市第四中心医院药剂科,天津 300140)
Author(s):
ZAN Shuang-jiangYU Zhi-jieLI Hai-yan
(Department of Pharmacy,Tianjin Fourth Central Hospital,Tianjin 300140,China)
关键词:
急性心肌梗死抗血小板药物血栓缺血
Keywords:
Acute myocardial infarctionAntiplatelet drugsThrombosisIschemia
分类号:
R542.2
DOI:
10.3969/j.issn.1006-1959.2020.12.011
文献标志码:
A
摘要:
急性心肌梗死是心内科常见的急危重症,目前针对急性ST段抬高型心肌梗死的治疗策略是实施早期再灌注治疗。尽早、完全、持续开通闭塞冠状动脉,恢复心肌水平的再灌注,能有效降低患者死亡率,改善患者预后。实施经皮冠状动脉介入(PCI)治疗是一种有效的再灌注策略,但在术后仍存在血栓性心血管事件发生风险。抗血小板药物越来越广泛被用于PCI术后预防不良心血管事件中,且取得一定效果。基于此,本文对抗血小板药物在急性心肌梗死PCI术后中的应用进行综述。
Abstract:
Acute myocardial infarction is a common critical illness in cardiology. The current treatment strategy for acute ST-segment elevation myocardial infarction is to implement early reperfusion therapy. Early, complete, and continuous opening and occlusion of coronary arteries and reperfusion to restore myocardial levels can effectively reduce patient mortality and improve patient prognosis. Percutaneous coronary intervention (PCI) is an effective reperfusion strategy, but there is still a risk of thrombotic cardiovascular events after surgery. Antiplatelet drugs are more and more widely used to prevent adverse cardiovascular events after PCI, and have achieved certain results. Based on this, this article reviews the application of antiplatelet drugs in PCI after acute myocardial infarction.

参考文献/References:

[1]赵珂,冯雨舟.直接经冠脉介入治疗与溶栓联合直接经冠脉介入治疗急性心肌梗死的疗效观察[J].黑龙江医学,2017,41(8):761-762.[2]黄震华.急性ST段抬高型心肌梗死溶栓治疗后经皮冠状动脉介入治疗的必要性和时机[J].中国新药与临床杂志,2016,35(1):24-29.[3]王蔚文.临床疾病诊断与疗效判断标准[M].北京:科学技术文献出版社,2010:181-182.[4]陈斌.不明原因的反复急性心肌梗死1例分析[J].心脑血管病防治,2019,19(5):486,489,[5]GurbelP A,JeongY H,Navarese EP,et al.Platelet-Mediated Thrombosis: From Bench to Bedside[J].Circ Res,2016,118(9):1380.[6]李艳花.阿司匹林抗血小板治疗的药学服务[J].临床合理用药杂志,2017,10(11):92-93.[7]王静.浅析阿司匹林抗血小板治疗的药学服务[J].世界临床医学,2016,10(23):130-130.[8]Raffaele P,Stephan W.Low-Dose Aspirin to Reduce the Risk for Myocardial Infarction Among Patients With Coronary Stents Undergoing Noncardiac Surgery[J].Ann Intern Med,2018, 168(4):289-290.[9]张天峰.氯吡格雷联合阿司匹林治疗急性心肌梗死的疗效观察[J].临床医学研究与实践,2017,2(23):14-15.[10]郭仕俊,苏令,章福彬,等.氯吡格雷联合肠溶性阿司匹林在急性心肌梗死治疗中的应用[J].蚌埠医学院学报,2017,42(4):458-461.[11]卫训,汪凤仪.双重抗血小板治疗稳定型缺血性心脏病[J].心血管病学进展,2018,39(6):188-192.[12]李平,李芳君,刘永刚.利用GRACE评分评估氯吡格雷与替格瑞洛在PCI患者术后抗栓治疗效果[J].中国医院药学杂志,2017,37(24):2482-2485.[13]宋炳慧,王书清,贾珊珊,等.替格瑞洛在急性心肌梗死溶栓后择期冠状动脉介入治疗的临床研究[J].中国临床药理学杂志,2016,32(12):1066-1068.[14]周永胜.P2Y12受体抑制剂替格瑞洛临床效应的研究进展[J].心血管病学进展,2015,36(2):158-161.[15]刘海江,支继新,盛昌宏,等.替格瑞洛、阿司匹林、替罗非班联合用于经皮冠状动脉介入治疗术后患者的疗效与安全性观察[J].医学研究杂志,2016,45(2):124-126,138.[16]赵雪银,王晓,严研,等.替格瑞洛对经CYP3A4途径代谢的他汀治疗急性冠脉综合征的影响[J].中国心血管病研究,2017,15(5):458-462.[17]杨金勇.盐酸替罗非班对急性心肌梗死冠脉多支病变PCI术后疗效及安全性研究[J].河北医学,2017,23(10):1674-1678.[18]柳美玲.PCI术联合西洛他唑治疗对急性心肌梗死患者血浆CKMB和cTnT水平的影响[J].当代医学,2018,24(33):180-182.[19]刘淼,管文娟,李琚平.西洛他唑联合氯吡格雷治疗不耐受阿司匹林的急性心肌梗死患者PCI术后的安全性及不良事件观察[J].安徽医学,2019,40(6):670-672.[20]丁霞.奥扎格雷与低分子肝素联合治疗进展性脑梗死的疗效观察[J].河南医学研究,2016,25(3):538-539.[21]王倩,张丽,黄俊,等.利伐沙班在高龄非瓣膜性心房颤动患者中的常用剂量及预后分析[J].岭南心血管病杂志,2019,25(6):638-641.[22]Hunstad JP,Krochmal DJ,Flugstad NA,et al.Rivaroxaban for Venous Thromboembolism Prophylaxis in Abdominoplasty:A Multicenter Experience[J].Aesthet Surg J,2016,36(1):60-66.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
 GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Medical Information,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
 YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Medical Information,2018,31(12):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
 MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Medical Information,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[4]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
 LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Medical Information,2018,31(12):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[5]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
 GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(12):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[6]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
 HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(12):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[7]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
 CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(12):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
[8]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
 GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2019,32(12):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[9]杨 震.急性心梗直接介入治疗术中慢血流及无复流的治疗进展[J].医学信息,2019,32(06):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
 YANG Zhen.Progress in the Treatment of Slow Blood Flow and no Reflow in the Treatment of Acute Myocardial Infarction[J].Medical Information,2019,32(12):56.[doi:10.3969/j.issn.1006-1959.2019.06.19]
[10]杜 敏.肌红蛋白联合肌钙蛋白检测在急性心肌梗死早期诊断中的应用价值分析[J].医学信息,2019,32(08):180.[doi:10.3969/j.issn.1006-1959.2019.08.058]
 DU Min.Application Value of Myoglobin Combined with Troponin Detection in Early Diagnosis of Acute Myocardial Infarction[J].Medical Information,2019,32(12):180.[doi:10.3969/j.issn.1006-1959.2019.08.058]

更新日期/Last Update: 1900-01-01